1, what is the harm of breast augmentation with prosthesis?
Rare lymphoma after female breast reconstruction
According to media reports, Lin Lei, a 43-year-old American, unfortunately developed breast cancer as early as 10 years ago. She finally underwent double mastectomy, survived the arduous chemotherapy, and finally underwent chest reconstruction surgery and implanted a prosthesis.
Since then, she has been reexamined on time until 20 13, and she found that her right breast was swollen to three times the size in a few days. Worried about the recurrence of breast cancer, she hurried to the hospital for examination. The result was a rare immune system tumor "anaplastic large cell lymphoma". The incidence of this kind of tumor is very low, and the symptoms are redness, swelling, heat and pain, and there are lumps in the breast and armpit. If the prosthesis is implanted, there will be swelling and effusion around it.
Lin Lei fell ill and went to the hospital for treatment every three months. Fortunately, further examination found that her lymphoma had not spread, and after treatment, she could be reviewed regularly.
Most of the "accidental" prostheses are rough, and there is little difference between different fillers.
We should know that silicone prosthesis breast augmentation surgery is one of the most mature and safest breast augmentation surgery methods in clinic, and it is also the most important and common breast augmentation surgery method in the world.
The FDA (Food and Drug Administration of the United States) only began to find out at 20 1 1 that if the surface of the prosthesis used for breast augmentation is rough and textured, the so-called "rough surface" prosthesis may cause this kind of cancer. Many people choose a rough prosthesis because the tissue will grow into these rough textures, which will help to fix the prosthesis, while smooth materials will slide more easily.
As of March this year, they have treated 359 cases of lymphoma caused by pseudomorph, of which 9 died. Among these reports, 23 1 has information about the surface characteristics of prostheses, of which 203 reports are rough prostheses and 28 reports are smooth prostheses. There is no obvious difference between silicone rubber and saline bag.
The pathogenic mechanism is still unclear, and no relevant reports have been found in China.
According to statistics, in Europe and the United States, the probability of this rare lymphoma is less than three in ten thousand, and the risk in Australia is slightly higher, about one in ten thousand to one in one thousand. However, the related pathological reports are still zero in China.
Professor Luo Shengkang from the Department of Breast Plastic Surgery of the Plastic Surgery Branch of the Chinese Medical Association introduced that this rare lymphoma is a new cancer species, and quite a few doctors don't know about it. The average incubation period is 8 years and the longest is 28 years. "Women with prosthetic breast augmentation should pay attention to whether there is persistent swelling and pain around the breast, whether there is sudden swelling and liquid inside, and go to the hospital for examination."
A plastic surgery professor in tongji hospital also said that these reports have not yet reached a final conclusion, and the pathogenesis has yet to be studied, so patients need not panic. In addition, the prognosis of this lymphoma is good, and radiotherapy and chemotherapy are generally not needed for timely detection and treatment.
France reminded doctors to inform the risks before implantation two years ago.
About 300,000 women in France have breast augmentation surgery every year. As early as 2065438+July 2005, the French National Cancer Institute published a report that there was a rare cancer related to the implantation of artificial breast prosthesis. However, the total incidence is very low and the prognosis is good. Those who have received breast augmentation with prosthesis need not worry too much.
According to the data provided by French National Drug and Health Products Safety Bureau and National Lymphoma Pathologists Organization, from 20 1 1 to 20 15, * * * 18 women who had undergone artificial breast implantation were diagnosed as "anaplastic large cell lymphoma".
The French Minister of Health said that it is not recommended for women with breast implants to take them out, as long as they have regular examinations. Relevant medical workers are also required to inform patients of the risk of the above cancer before operation. (Reporter Yan Yan)
2. What is the effect of breast augmentation with prosthesis?
1. Its curative effect is related to the selection of thoracic prosthesis materials. At present, the materials and techniques of breast augmentation prosthesis are constantly updated and improved, which has become a mature and reliable breast enhancement method in the world. In addition, many prosthetic materials are advanced and safe, such as Mantuo in the United States, es in France and Weining in China. The texture and biocompatibility of these breast augmentation materials can ensure the appearance and feel of breast augmentation.
2. The surgeon in charge of the operation decides whether the shape of the prosthesis after breast augmentation is natural and beautiful. Doctors not only need to implant the prosthesis into the chest through a scalpel, but also have the shape design of the chest, so that the design of the size and height of the chest is more in line with the natural aesthetics and the objective conditions of the patient. Therefore, choosing regular plastic surgery institutions and professional doctors plays an important role in the curative effect of surgery.
3. The limitation of the operator's own conditions also affects its curative effect. The size of the implanted thoracic prosthesis is limited by the existing chest tissue of the patient. For example, the elasticity of skin or the volume of existing chest tissue may hinder the expansion of the chest. Generally speaking, the bigger the bust, the bigger the implant. The implantation position of thoracic prosthesis also plays a decisive role in the size of prosthesis. If implanted under pectoralis major, the size of thoracic prosthesis will also be limited.